Media headlines about Dynatronics (NASDAQ:DYNT) have trended somewhat positive on Monday, Accern Sentiment reports. The research group scores the sentiment of media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Dynatronics earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned media coverage about the medical equipment provider an impact score of 47.3109159184918 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Separately, Zacks Investment Research upgraded Dynatronics from a “hold” rating to a “buy” rating and set a $3.00 price objective for the company in a research note on Tuesday, December 5th.
Shares of Dynatronics (DYNT) traded down $0.12 during trading hours on Monday, hitting $2.68. The stock had a trading volume of 9,600 shares, compared to its average volume of 20,315. Dynatronics has a 1 year low of $2.10 and a 1 year high of $3.75. The stock has a market capitalization of $21.26, a PE ratio of -2.33 and a beta of -0.53. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.83 and a current ratio of 1.62.
In other news, Director Brian Larkin acquired 40,000 shares of Dynatronics stock in a transaction dated Thursday, November 30th. The stock was purchased at an average cost of $2.50 per share, for a total transaction of $100,000.00. Following the completion of the purchase, the director now directly owns 80,276 shares in the company, valued at approximately $200,690. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, major shareholder Stuart Essig acquired 27,455 shares of Dynatronics stock in a transaction dated Wednesday, January 3rd. The stock was purchased at an average price of $2.77 per share, with a total value of $76,050.35. Following the completion of the purchase, the insider now owns 856,169 shares of the company’s stock, valued at $2,371,588.13. The disclosure for this purchase can be found here. Over the last 90 days, insiders bought 369,015 shares of company stock valued at $930,372. Company insiders own 51.80% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Dynatronics (DYNT) Receiving Somewhat Favorable News Coverage, Study Shows” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/19/dynatronics-dynt-receiving-somewhat-favorable-news-coverage-study-shows.html.
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.